Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/19/2025

Treatment of Staphylococcal Scalded Skin Syndrome (SSSS)

Initial Antibiotic Selection

  • Cefazolin can be considered if the allergy is not type 1 hypersensitivity, according to the Infectious Diseases Society of America 1

MRSA Coverage Indications

  • Vancomycin should be used in patients who are critically ill or not improving on beta-lactam therapy, as recommended by the Infectious Diseases Society of America 2
  • Vancomycin should be used in communities with high prevalence of methicillin-resistant S. aureus (MRSA), as recommended by the Infectious Diseases Society of America 2
  • Vancomycin should be used in confirmed MRSA infection on culture, as recommended by the Infectious Diseases Society of America 2
  • Vancomycin dosing is 15 mg/kg/dose IV every 6 hours for children, as recommended by the Infectious Diseases Society of America 3
  • Linezolid is an alternative MRSA-active agent, with a dosing of 10 mg/kg/dose PO/IV every 8 hours for children <12 years, as recommended by the Infectious Diseases Society of America 3

Adjunctive Antibiotic Therapy

  • Clindamycin should be considered as adjunctive therapy to stop exotoxin production at the bacterial ribosome level, with a dosing of 10-13 mg/kg/dose IV every 6-8 hours, as recommended by the Infectious Diseases Society of America 2

Topical Management

  • Mupirocin 2% topical ointment is recommended for localized minor staphylococcal skin infections, as recommended by the Infectious Diseases Society of America 2

Duration of Therapy

  • Treatment duration should be guided by clinical response, with most SSSS cases requiring 7-14 days of therapy, as recommended by the Infectious Diseases Society of America 1

Key Clinical Pitfalls

  • Tetracyclines should not be used in children <8 years of age, as recommended by the Infectious Diseases Society of America 2

Clindamycin Use in Children with Staphylococcal Scalded Skin Syndrome

Primary Considerations for Clindamycin Therapy

  • In stable hospitalized children without ongoing bacteremia or intravascular infection, clindamycin 10-13 mg/kg/dose IV every 6-8 hours can be used empirically ONLY if local clindamycin resistance rates are low (<10%), with transition to oral therapy if the strain is susceptible, as recommended by the Infectious Diseases Society of America 4, 5

Adjunctive Therapy and Resistance Considerations

  • Tetracyclines should not be used in children <8 years of age, according to the American Academy of Pediatrics 4, 5
  • Add clindamycin as adjunctive therapy if the patient is critically ill or has extensive disease, initial response to beta-lactam is suboptimal after 24-48 hours, or to actively suppress ongoing toxin production, as suggested by the Clinical Infectious Diseases guidelines 4

Treatment of Staphylococcal Scalded Skin Syndrome

Critical Diagnostic Distinction

  • The British Journal of Dermatology notes that before initiating therapy, it is crucial to exclude toxic epidermal necrolysis (TEN), which has a different treatment approach and significantly worse prognosis, and key differentiating features of SSSS include mucosal surfaces not being involved and positive Nikolsky sign with superficial skin sloughing 6

Staphylococcal Scalded Skin Syndrome Treatment

Initial Antibiotic Selection

  • For methicillin-susceptible Staphylococcus aureus (MSSA) infections, nafcillin or oxacillin are the preferred parenteral drugs, with a dosage of 100-150 mg/kg/day in 4 divided doses intravenously, according to the Infectious Diseases Society of America 7
  • Cefazolin 50 mg/kg/day in 3 divided doses intravenously can be used in patients with penicillin allergy, except those with immediate hypersensitivity reactions, as recommended by the Infectious Diseases Society of America 7

Anti-MRSA Therapy

  • Vancomycin is the preferred parenteral drug for MRSA infections, with a pediatric dosage of 40 mg/kg/day in 4 divided doses intravenously, as recommended by the Infectious Diseases Society of America 7
  • Linezolid can be used as an alternative, with a dosage of 10 mg/kg/dose every 8 hours for children <12 years, and 600 mg twice daily for children >12 years, as recommended by the Infectious Diseases Society of America 8

Adjuvant Antibiotic Therapy

  • Clindamycin can be used as adjuvant therapy, with a dosage of 10-13 mg/kg/dose every 6-8 hours intravenously, but only if local resistance rates are low (<10%), as recommended by the Infectious Diseases Society of America 8

Wound Management

  • Wounds should be kept covered with clean, dry dressings, as recommended by the Infectious Diseases Society of America 8

Contraindications and Precautions

  • Tetracyclines should not be used in children <8 years due to the risk of tooth discoloration, as recommended by the Infectious Diseases Society of America 8
  • Inducible resistance to clindamycin is common in MRSA, and should be verified before use, as recommended by the Infectious Diseases Society of America 7, 8

REFERENCES

← Return to Home